The integrated care pathway for melanoma: the Istituto Dermopatico dell’Immacolata experience in Rome
Il percorso diagnostico terapeutico e assistenziale nella gestione del paziente con melanoma cutaneo: l’esperienza dell’IDI di Roma
DOI:
https://doi.org/10.33393/abtpn.2019.289Keywords:
Continuity of care, Integrated Care Pathway, Melanoma, Patient careAbstract
Introduction: The Integrated Care Pathway (ICP) represents a multidisciplinary outline of anticipated care, placed in an appropriate timeframe, to support patients with specific conditions or symptoms. The aim of this paper is to define the ICP for patients with melanoma referring to the “Istituto Dermopatico dell’Immacolata-IRCCS di Roma e Villa Paola” (“Center”).
Methods and results: A multidisciplinary group (oncologists, dermatologists, surgeons, pathologists etc.) was defined as well as a facilitator to act as a link between all experts. The first step of ICP development was a review of current practice for patients with melanoma referring to the Center. This first step had the scope to define the multidisciplinary process map (a “picture” of the care plan) for patients with melanoma. The process map defined: i) the activities performed during delivery of care to the patients, ii) the responsibilities for these activities and iii) potential problem areas or opportunities for improvements. The process map formed the basis of the final ICP document.
Conclusion: The adoption of melanoma ICP will allow the multidisciplinary group to ensure that clinical guidelines and available evidence are incorporated into everyday practice. (Oncology, HTA & Market Access)
Downloads
References
NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma. Version 1.2019. January 17, 2019.
Dummer R, Hauschild A, Lindenblatt N et al.; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26 Suppl 5:v126-32.
Garbe C, Peris K, Hauschild A et al.; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016. Eur J Cancer. 2016 Aug;63:201-17.
AIOM (Associazione Italiana di Oncologia Medica). Linee guida Melanoma. Edizione 2018.
http://e-p-a.org/sito-internet-e-p-a/percorsi-diagnostici-terapeutici-e-assistenziali-pdta/ Accesso Novembre 2017.
Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017 Nov;67(6):472-92.
Wong SL, Faries MB, Kennedy EB et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. Ann Surg Oncol. 2018 Feb;25(2):356-77.
Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ 1998 Jan 10;316(7125):133-7
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2019 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to AboutOpen agree to publish their articles under the Creative Commons NonCommercial 4.0 International License (CC BY-NC 4.0), which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.
Accepted 2019-05-22
Published 2019-06-07
